Scinai Immunotherapeutics Investor Relations Material
Latest events
Study Update
Scinai Immunotherapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Scinai Immunotherapeutics Ltd
Access all reports
Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals Ltd., is an Israeli biopharmaceutical company primarily engaged in the development, manufacture, and commercialization of innovative biological products. The company's focus is on inflammation and immunology, with a particular emphasis on autoimmune and infectious diseases. Scinai's product development pipeline includes a range of nanosized antibodies, known as NanoAbs, derived from alpacas. These antibodies target various diseases with significant unmet medical needs. Additionally, Scinai operates a boutique contract development and manufacturing organization (CDMO) that provides comprehensive services to pharmaceutical, biotech, and alternative protein food tech companies. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Key slides for Scinai Immunotherapeutics Ltd
Corporate Presentation
Scinai Immunotherapeutics Ltd
Corporate Presentation
Scinai Immunotherapeutics Ltd
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
SCNI
Country
🇺🇸 United States